NCT00058188 2020-12-08
Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Northwestern University
Phase 3 Terminated
Clinical Trials
4 trialsNCT00005073 2013-05-01
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
Novartis
Phase 3 Terminated
NCT00258765 2010-04-26
Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.
Novartis
Phase 2 Terminated
NCT00391950 2009-11-23
Maintaining Bone Strength in Men With Prostate Cancer
Novartis
Phase 3 Terminated